"I think the most important part of science is being prepared to be wrong." —Judith Campisi (1948–2024) cell.com/cell-metabolis…

Welcome Nathan Price, PhD to Buck as Prof & Co-Dir of Center for Human Healthspan! He is widely recognized for his work in systems biology, AI and bioengineering. His expertise will accelerate our efforts to allow us to live better longer @ISBNathanPrice buckinstitute.org/news/health-ai…

Cancer in the young is on the rise worldwide, but the basis for this is not known. A new review covers it well, open-access cell.com/cell-reports-m… Alberto Bardelli @GianMau1990 Cell Reports Medicine

It has been difficult to sort out why there's so much waning immunity after Covid vaccination—the evolution of the virus or the durability of vaccine-induce immunity? A new nature paper today raises concern about the lack of bone marrow long-lived plasma cells induced by

A new, multimodal brain atlas of #Alzheimer's disease open-data resource characterizes 2 epochs of the disease, the early slow one, highlighting loss of somatostatin (Sst) neurons, and the later exponential phase nature.com/articles/s4159… Nature Neuroscience Mike Hawrylycz Allen Institute

Just a day away – still plenty of time to register for this FREE resource! #microbiome #ISBMicro24 isbscience.org/microbiome2024/

In context of the dearth of primary care physicians and serious problems with access, a realistic appraisal for how incorporating #AI in medicine should be compared to standard of care nejm.org/doi/full/10.10… NEJM Isaac Kohane

One of the most exciting advances in medicine has been the use of engineered T cells (CAR-T) to achieve 1-shot durable treatment (possible cure) of some autoimmune diseases. Here's a new review Science Translational Medicine, with over 50 ongoing clinical trials! science.org/doi/10.1126/sc… Dr. Christopher M. Jewell

We're excited to launch our new journal Longevity, a new initiative to promote longevity science and all related fields. All open acess publication fees will be waived for the first year! Submit your publications today: tandfonline.com/journals/tpml2… Our editors are Richard Siow

New NEJM A whopping (~90%) reduction of progression to Type 2 diabetes with tirzepatide (GLP-1 drug, dual receptor) vs placebo in a randomized trial of >2,500 participants with obesity, absolute reduction of 10/100 treated nejm.org/doi/full/10.10… by Ania M. Jastreboff, MD, PhD and

We're learning how to control the immune response, like a rheostat, even in the brain. Implications for understanding the basis and potential treatment of autoimmune conditions like multiple sclerosis, #LongCovid, #MECFS, and brain cancer. A brief review of 6 recent, important

Exciting vision for the future of healthcare in The Age of Scientific Wellness by Dr. Leroy Hood and Nathan Price. Quick hits: PREVENTION *Doctors should be evaluated based on how well they prevent, not just treat, disease *Transitions from wellness to disease are often

+ 51 new speakers added to Vitalist Bay in Berkeley, CA. The world's biggest longevity event! Join us, starting with Unlimited Health Conference, from next Saturday April 5th, to April 7th. At Vitalist Bay, you'll have the healthiest time of your life!

Jack Scannell, Jonathan Anomaly, Léo PioLopez, Nathan Price, Michael Andregg, Boyang bio/acc, Nish, Dave Messina, Sam Rodriques, Erika Alden DeBenedictis, Sonia Arrison, Kris Borer, Becca Ziegler 🌐, Max Marty, Eric Magro, Sajad Zalzala, MD, Madam Mitochondria

Hang out with the leaders reshaping human longevity and experience: 🦾DEXA scans 💪🏼Continuous Glucose Monitors 🧬DNA sequencing 🩸100-biomarker blood tests 🏃metabolic health tests 🧖spa & sauna rejuvenation. vitalistbay.com

Jonathan Anomaly Michael Andregg Tim Urban Matt Kaeberlein Andrew Steele kennethlou Mito Health We cannot cure chronic diseases with care after illness approach — we need to change it. - Nathan Price

This Nathan Price, on AI+wellness, worth reading b/c (as noted: timmermanreport.com/2025/04/can-yo…) he's smart, thoughtful, & describes vision for AI as data integrator+personalization machine medcitynews.com/2025/04/the-bi…. Key issues: 1. Future vs today? 2. Premise slippery/dif to falsify?

The biggest mistake when thinking about AI Agents is to narrowly see them as replacing work that already gets done. The vast majority of AI Agents will be used to automate tasks that humans never got around to doing before because it was too expensive or time consuming.

Latest Timmerman Report looks @ common themes uniting our collective aspirations 4 AI in geroscience, wellness, nutrition, R&D; asks how far r we from realizing these loft ambitions (estimates vary). Plus Explanatory Models, Epic podcast. timmermanreport.com/2025/05/our-co… Nathan Price

Coming soon to UAE 🌟 "Revive ME will welcome leading policymakers, regulators, researchers, longevity scientists, healthtech entrepreneurs, and wellness pioneers who are shaping the future of healthy longevity...@" 🔗revivemeexpo.com/conference/why… | Nathan Price Agingdoc🩺Dr David Barzilai🔔MD PhD MS MBA DipABLM